ClinicalTrials.govpublic full text
A Phase1 Clinical Trial Evaluating Locoregional Delivery Of Engineered NK Cells Containing IL13Ra And EGFvIII Chimeric Antigen Receptor (CAR), IL-21 Secretion And Deleted TGF-BetaR2 And NR3C1 In Recurrent Glioblastoma
phase 1, nk cell, il13ra, egfrviii, chimera antigen receptor (car), nr3c1, recurrent glioblastoma, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 845159
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.